Kennedy Capital Management’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-47,566
Closed -$698K 719
2023
Q3
$698K Buy
+47,566
New +$741K 0.02% 595
2017
Q3
Sell
-209,999
Closed -$5.57M 759
2017
Q2
$5.57M Buy
209,999
+7,770
+4% +$207K 0.11% 358
2017
Q1
$5.53M Buy
+202,229
New +$5.16M 0.1% 381
2015
Q4
Sell
-217,018
Closed -$4.88M 752
2015
Q3
$4.88M Sell
217,018
-87,678
-29% -$2.25M 0.1% 362
2015
Q2
$9.11M Sell
304,696
-47,812
-14% -$1.35M 0.16% 222
2015
Q1
$8.58M Buy
352,508
+25,943
+8% +$583K 0.15% 236
2014
Q4
$7.27M Sell
326,565
-25,081
-7% -$595K 0.13% 284
2014
Q3
$8.88M Buy
+351,646
New +$9.74M 0.17% 210

Other funds holding TBI

Kennedy Capital Management's TBI Position: Q4 2023 in Review

Kennedy Capital Management sold out of Trueblue (TBI) in Q4 2023, closing a stake of 47,566 shares — an estimated $698K sold.

Kennedy Capital Management first reported a position in TBI in Q3 2014 and held it in 8 quarters. The position peaked at $9.11M in Q2 2015. 152 funds tracked by Wall St. Rank hold TBI as of Q4 2023.

  • Kennedy Capital Management reported no remaining Trueblue position as of Q4 2023 after selling out during the quarter.
  • Kennedy Capital Management sold 47,566 Trueblue shares in Q4 2023, an estimated $698K.
  • Kennedy Capital Management first reported a position in Trueblue in Q3 2014 and held it in 8 quarters.
  • Kennedy Capital Management's Trueblue position peaked at $9.11M in Q2 2015.
  • 152 funds tracked by Wall St. Rank held Trueblue as of Q4 2023.

Based on Kennedy Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.